Breast Cancer Recurrence after Smooth versus Textured Implant-Based Breast Reconstruction: A Matched Cohort Study

Zhen‐Yu Wu(Ulsan College), BeomSeok Ko(Ulsan College), Jin Sup Eom(Ulsan College), Hyun Ho Han(Ulsan College), Hak Hee Kim(Alfred I. duPont Hospital for Children), Sei‐Hyun Ahn(Ulsan College), Byung‐Ho Son(Ulsan College), Gyungyub Gong(Ulsan College), Jing Han(Hebei Medical University), Sung‐Bae Kim(Ulsan College)
Plastic & Reconstructive Surgery
August 9, 2022
10.1097/prs.0000000000009491
Cited by 3

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|The Lancet|2022|664
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|594